The legacy of Viagra, and its creator copyright, presents a complex case study for investors. Originally a blockbuster drug, yielding billions in income, its intellectual property lapse created a deluge of generic competition , significantly diminishing its market share . While specific businesses may seek to capitalize on male sexual dysfunction,